FDA halts sale of more than 50,000 flavored e-cigarette products; health systems in Idaho and Oregon struggle to meet the influx of patients with COVID-19; drop in breast cancer screening rates seen throughout pandemic.
The FDA has denied marketing applications to around 55,000 flavored e-cigarette products claiming they failed to show the products protect public health. This is the first time the agency has issued marketing denial orders for e-cigarettes and prompts all items to be removed from the market or risk enforcement. Specifically, the agency found products from JD Nova Group LLC, Great American Vapes, and Vapor Salon lacked sufficient evidence showing they benefit adult smokers that is sufficient to overcome the public health threat posed by youth use of the products.
Hospitalizations in Oregon for COVID-19 have hit record highs this week, while intensive care unit (ICU) beds are at 93% capacity, CBS News reports. Many health systems have canceled elective surgeries and the National Guard has been deployed to keep up with the flood of critically ill patients. Meanwhile in Idaho, COVID-19 has forced hospitals past capacity and to the brink of crisis, according to the Associated Press. Since July 24, COVID-19–related hospital admissions have doubled every 2 weeks in the state, and health systems report getting calls from overwhelmed facilities in neighboring states, including Oregon.
New data show that across 32 community health centers in the United States, rates of breast cancer screenings dropped by 8% between 2019 and 2020, the Center for Infectious Disease Research and Policy reports. All sites included in the analysis were part of an American Cancer Society grant program working to address disparities, but the figures show that minorities and uninsured individuals were disproportionately affected by this decrease. Projections estimated that had prepandemic increases in rates continued, more than 63% of eligible patients may have completed a mammogram in 2020.
Preventing Respiratory Illness and Death Through Tighter Air Quality Standards
June 1st 2021On this episode of Managed Care Cast, a research scholar at the Marron Institute of Urban Management at New York University discusses the latest findings in the Health of the Air report, which was presented at the recent American Thoracic Society 2021 International Conference.
Listen
Multidisciplinary Approaches to Pediatric Obstructive Sleep Apnea: A Review of Respiratory Therapies
August 13th 2025The treatment of pediatric obstructive sleep apnea syndrome is moving toward a personalized, multidisciplinary approach that combines surgical options with a growing number of nonsurgical alternatives, to better address the unique needs of each child.
Read More
Chronic Respiratory Diseases Linked to Other Noncommunicable Diseases in Vulnerable Countries
August 4th 2025Despite their devastating global impact, chronic respiratory diseases remain a hidden threat in low- and middle-income countries, often going undiagnosed in adults who are already battling other noncommunicable diseases.
Read More
RSV's Impact on Heart Health Emphasizes Broader Risks, Vaccination Importance for Older Adults
July 23rd 2025Respiratory syncytial virus (RSV) poses a significant, often overlooked, risk for serious cardiovascular complications in older adults, underscoring the need for vaccination in this population regardless of their preexisting health conditions.
Read More